Abstract
Costello syndrome is a multiple congenital anomaly and mental retardation syndrome characterized by coarse face, loose skin, cardiomyopathy and predisposition to tumors. We identified four heterozygous de novo mutations of HRAS in 12 of 13 affected individuals, all of which were previously reported as somatic and oncogenic mutations in various tumors. Our observations suggest that germline mutations in HRAS perturb human development and increase susceptibility to tumors.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Costello, J.M. N. Z. Med. J. 74, 397 (1971).
Hennekam, R.C. Am. J. Med. Genet. C Semin. Med. Genet. 117, 42–48 (2003).
Tartaglia, M. et al. Nat. Genet. 29, 465–468 (2001).
Troger, B. et al. Am. J. Med. Genet. A 121, 82–84 (2003).
Tartaglia, M., Cotter, P.D., Zampino, G., Gelb, B.D. & Rauen, K.A. Clin. Genet. 63, 423–426 (2003).
Niihori, T. et al. J. Hum. Genet. 50, 192–202 (2005).
Tartaglia, M. et al. Nat. Genet. 34, 148–150 (2003).
Bos, J.L. Cancer Res. 49, 4682–4689 (1989).
Oliva, J.L. et al. J. Biol. Chem. 279, 33480–33491 (2004).
Gripp, K.W. et al. Am. J. Med. Genet. 108, 80–87 (2002).
Land, H. et al. Science 222, 771–778 (1983).
Colby, W.W. et al. Mol. Cell. Biol. 6, 730–734 (1986).
Seeburg, P.H. et al. Nature 312, 71–75 (1984).
Fasano, O. et al. Proc. Natl. Acad. Sci. USA 81, 4008–4012 (1984).
Hahn, W.C. et al. Nature 400, 464–468 (1999).
Acknowledgements
We thank the individuals and their families for participating in this study; the doctors for referring the cases; the “Diagnosi PrePostnatale Malattie Metaboliche” Laboratory (G. Gaslini Institute) for providing us with specimens from the “Cell line and DNA bank from patients affected by genetic diseases” Biobank, supported by TELETHON grants; and the Japan Health Sciences Foundation for providing us with control fibroblasts (TIG118-120) from Health Science Research Resources Bank. This work was supported by Grants-in-Aid from the Ministry of Education, Culture, Sports, Science and Technology of Japan to Y.A.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Supplementary information
Supplementary Fig. 1
Photographs of patients' faces and histopathology of cardiomyopathy and ganglioneuroblastoma. (PDF 925 kb)
Supplementary Fig. 2
Mutation analysis of 12 affected individuals and their families. (PDF 1360 kb)
Supplementary Table 1
Clinical data of Japanese individuals with Costello syndrome. (PDF 116 kb)
Rights and permissions
About this article
Cite this article
Aoki, Y., Niihori, T., Kawame, H. et al. Germline mutations in HRAS proto-oncogene cause Costello syndrome. Nat Genet 37, 1038–1040 (2005). https://doi.org/10.1038/ng1641
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/ng1641
This article is cited by
-
Cancer in Costello syndrome: a systematic review and meta-analysis
British Journal of Cancer (2023)
-
Cancer Predisposition Genes in Adolescents and Young Adults (AYAs): a Review Paper from the Italian AYA Working Group
Current Oncology Reports (2022)
-
Molecular and clinical profile of patients referred as Noonan or Noonan-like syndrome in Greece: a cohort of 86 patients
European Journal of Pediatrics (2022)
-
Integrated in silico MS-based phosphoproteomics and network enrichment analysis of RASopathy proteins
Orphanet Journal of Rare Diseases (2021)
-
Identification of a germline CSPG4 variation in a family with neurofibromatosis type 1-like phenotype
Cell Death & Disease (2021)
